SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-11-049439
Filing Date
2011-09-15
Accepted
2011-09-15 16:37:15
Documents
1
Period of Report
2011-09-13

Document Format Files

Seq Description Document Type Size
1 ANNUAL DIRECTOR EQUITY COMPENSATION rrd322021.html 4  
1 ANNUAL DIRECTOR EQUITY COMPENSATION rrd322021.xml 4 4069
  Complete submission text file 0001181431-11-049439.txt   5530
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Issuer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
CHESS ROBERT (Reporting) CIK: 0001227886 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-24006 | Film No.: 111093264